Table 3 Univariate (chi-square) and multivariate (logistic regression) analysis for clinicopathological features associated with late recurrence after completion of 5 years tamoxifen

Age (<50 vs ≥ 50 Years)

0.098

0.981

0.954–1.008

0.168

Menopausal status (pre-vs-post-)

0.409

Tumor size (>2 cm vs ≤2 cm)

0.002

1.297

0.762–2.207

0.338

ALN^a metastasis (yes vs no)

<0.001

2.731

1.615–4.618

<0.001

PgR^b (negative vs posituve)

0.420

HER2 (positive vs negative)

0.051

Histologic grade (Gr III vs Gr I or II)

0.018

1.396

0.786–2.479

0.256

Ki-67 (high vs low)^c

0.480

Radiotherapy (yes vs no)

0.134

Chemotheraphy (yes vs no)

0.434